다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lexaria Bioscience Corporation (LEXXW)
Lexaria Bioscience Corporation (LEXXW) 뉴스

LEXXW

Lexaria Bioscience (LEXXW)

Lexaria Bioscience Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LEXXW

1

일자	시간	출처	헤드라인	심볼	기업
2024/06/04	02:05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/16	06:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	05:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/22	21:18	InvestorsHub NewsWire	Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/21	20:27	InvestorsHub NewsWire	Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/15	21:14	InvestorsHub NewsWire	Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/06/03	21:05	InvestorsHub NewsWire	Lexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/20	20:16	InvestorsHub NewsWire	Lexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..cont	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/12	20:18	InvestorsHub NewsWire	Lexaria Strengthens its International Patent Portfolio to 19 Patents Granted	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/06	20:35	InvestorsHub NewsWire	Lexaria Issues Successful Results from First 2021 Study, HYPER-A21-1	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/04/14	20:37	InvestorsHub NewsWire	Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/04/06	20:16	InvestorsHub NewsWire	Lexaria to Evaluate DehydraTECHTM in Multiple New Markets	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/24	21:00	InvestorsHub NewsWire	Lexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD Beverages	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/16	20:39	InvestorsHub NewsWire	Lexaria's Antiviral Drug Evaluation Program Progressing	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/15	21:30	InvestorsHub NewsWire	Rapid Progress in Hypertension Studies by Lexaria	NASDAQ:LEXXW	Lexaria Bioscience Corporation

검색 관련기사 보기:NASDAQ:LEXXW

1

Wrapped Centrifuge

Flexshares Esg & Climate...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관